Editorial Guidelines, Independence & Corrections Policy

Binary Options Singapore is an independent financial education and research publication focused on retail derivatives, foreign exchange, and proprietary trading evaluations for market participants in Singapore. This document sets out our editorial standards, research protocols, commercial disclosures, and formal corrections policy.

1. Editorial Independence & Integrity

Editorial integrity is the absolute foundation of our research. Our editorial verdicts, platform assessments, and risk warnings are determined independently by our research team. We adhere to the following non-negotiable principles:

• No Paid Editorial Placements: We do not accept sponsored content, paid reviews, guest-post advertising, or paid rank positioning. Commercial entities cannot pay to alter editorial evaluations, star ratings, or pros and cons.
• Uncompromising Risk Reporting: Unlicensed platforms, entities on the Monetary Authority of Singapore (MAS) Investor Alert List (IAL), and offshore jurisdictions lacking statutory dispute resolution are always prominently exposed with high-risk warnings, regardless of any affiliate relationship.
• Editorial Separation: Our commercial affiliate relationships are managed independently from our editorial review process. The existence of a commercial relationship does not improve a platform's score, and the absence of one does not penalize it.

2. Reader Funding & Affiliate Disclosure

Operating an independent research portal requires server infrastructure, development resources, and continuous data monitoring. To keep all content freely accessible to the public without paywalls, Binary Options Singapore participates in affiliate partner programs:

• When a reader clicks a referral link on our website to visit an external broker or evaluation firm and subsequently opens an account, we may receive compensation from the provider.
• This compensation comes at no additional cost to the trader. In many instances, affiliate links provide exclusive promotional fee discounts or enhanced demo evaluation terms.
• Affiliate links are clearly identified with standard rel="noopener sponsored" attributes in compliance with search engine guidelines and consumer protection transparency laws.
• We never recommend a high-risk or blacklisted platform to generate affiliate commissions. Platforms that fail our baseline regulatory or counterparty safety checks are either classified as high risk or excluded from recommended tables.

3. Evidence Hierarchy & Regulatory Sourcing

Financial and legal claims published on Binary Options Singapore are grounded in verifiable documentation. We enforce a strict source hierarchy:

4. Factual Data vs. Editorial Assessment

We clearly distinguish between objective factual specifications and subjective editorial opinions:

• Objective Factual Specifications: Regulatory license numbers, corporate registration entities, published minimum deposit thresholds, statutory leverage caps, contractual profit split percentages, and verified fee tables are treated as verifiable facts verified against primary sources.
• Editorial Assessments: Star ratings, usability commentary, pros and cons summaries, and suitability recommendations represent our editorial opinion based on structured criteria outlined in our Review Methodology.

5. Risk Disclosures & No Profit Guarantees

Binary Options Singapore does not provide investment advisory services, portfolio management, or personalized financial advice. Speculative financial instruments—including binary options, contracts for difference (CFDs), margin forex, and proprietary evaluation challenges—involve a high degree of capital risk:

• Binary contracts feature fixed payout structures with negative mathematical expectancy; retail traders frequently lose 100% of their staked funds.
• Retail foreign exchange and CFD trading carry high risk due to financial leverage; between 70% and 89% of retail investor accounts lose money when trading CFDs with providers.
• Proprietary trading evaluations involve non-refundable challenge fees, strict trailing drawdown parameters, and no guarantee of receiving a funded account or sustained payouts.
• We never guarantee profits, advertise “risk-free” strategies, or encourage trading with funds required for daily living, emergency savings, or family welfare.

6. Corrections & Factual Rectification Policy

We are committed to prompt transparency whenever a factual inaccuracy, broken calculation, or outdated regulatory classification is identified:

• Correction Timeline: We aim to review reported factual errors promptly and prioritize material regulatory or financial corrections, typically updating verified errors within 48 hours (two business days) of receipt.
• Material Corrections: When a material factual error affects an overall evaluation or conclusion, an editorial correction notice is appended to the article, and the article's dateModified timestamp is updated.
• Minor Adjustments: Routine typographical fixes, formatting improvements, or internal link additions do not reset the editorial modification date.

7. Content Update Triggers & Freshness Architecture

Platform specifications change frequently. To ensure ongoing accuracy, we maintain a continuous audit schedule triggered by:

• Regulatory Alerts: Immediate updates when the MAS updates its Financial Institutions Directory or adds a broker to the Investor Alert List.
• Fee & Condition Shifts: Re-audits whenever a broker or prop firm alters its challenge pricing, drawdown calculation model (balance vs. equity), or minimum deposit thresholds.
• Tax & Statutory Guidance: Updates following new circulars or e-Tax guides issued by IRAS or CPF Board regarding trading income, Badges of Trade, or self-employment requirements.

8. Submitting Corrections & Feedback

If you are a trader, compliance officer, or broker representative and notice an outdated fact, incorrect fee schedule, or inaccurate regulatory reference on any page of this site, please submit supporting primary documentation to our editorial team via our About Page. We review all evidence submissions against our primary source hierarchy.